Steven Cohen Castle Biosciences Inc Transaction History

Point72 Asset Management, L.P.

$51 Billion
Q3 2025

A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Castle Biosciences Inc stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 336,958 shares of CSTL stock, worth $11.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

336,958

Holding current value

$11.3 Million

% of portfolio

0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$14.65 - $24.65 $4.94 Million - $8.31 Million	336,958 New	336,958 $7.67 Million
Q1 2025 May 15, 2025	SELL	$18.76 - $32.72 $5.83 Million - $10.2 Million	-310,886 Reduced 56.82%	236,218 $4.73 Million
Q4 2024 Feb 14, 2025	BUY	$26.52 - $34.67 $1.27 Million - $1.66 Million	47,912 Added 9.6%	547,104 $14.6 Million
Q3 2024 Nov 14, 2024	BUY	$17.4 - $31.47 $7.75 Million - $14 Million	445,415 Added 828.26%	499,192 $14.2 Million
Q2 2024 Aug 14, 2024	BUY	$18.84 - $24.94 $1.01 Million - $1.34 Million	53,777 New	53,777 $1.17 Million

Q3 2023 Nov 14, 2023	BUY	$13.28 - $20.3 $586,976 - $897,260	44,200 New	44,200 $746,000
Q1 2023 May 15, 2023	BUY	$19.47 - $28.49 $1.63 Million - $2.38 Million	83,466 Added 41.45%	284,847 $6.47 Million
Q4 2022 Feb 14, 2023	BUY	$18.08 - $30.0 $3.64 Million - $6.04 Million	201,381 New	201,381 $4.74 Million
Q2 2022 Aug 15, 2022	SELL	$16.0 - $45.99 $9.97 Million - $28.7 Million	-623,291 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$33.17 - $46.98 $4.66 Million - $6.6 Million	140,439 Added 29.09%	623,291 $28 Million
Q4 2021 Feb 14, 2022	BUY	$39.06 - $67.58 $14.8 Million - $25.7 Million	379,673 Added 367.98%	482,852 $20.7 Million
Q3 2021 Nov 15, 2021	BUY	$60.13 - $77.6 $6.2 Million - $8.01 Million	103,179 New	103,179 $6.86 Million
Q1 2021 May 17, 2021	SELL	$58.92 - $97.33 $4.78 Million - $7.9 Million	-81,145 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$43.6 - $73.05 $3.54 Million - $5.93 Million	81,145 New	81,145 $5.45 Million
Q3 2020 Nov 16, 2020	SELL	$38.47 - $52.03 $1.69 Million - $2.29 Million	-44,022 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$27.28 - $43.01 $449,083 - $708,030	16,462 Added 59.73%	44,022 $1.66 Million
Q1 2020 May 15, 2020	BUY	$23.08 - $35.53 $636,084 - $979,206	27,560 New	27,560 $822,000

Others Institutions Holding CSTL

# of Institutions

185

Shares Held

27M

Call Options Held

42.2K

Put Options Held

9.3K

View Full List

About CASTLE BIOSCIENCES INC

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $880M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

More about CSTL

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account